Master of Science (MS), Wright State University, 2013, Pharmacology and Toxicology
Gold nanoparticles (GNPs) possess unique physicochemical properties that may
facilitate entry into the central nervous system (CNS) where they may act therapeutically.
There is little information on biodistribution or inflammatory effects of GNPs in specific
brain regions. Brain Localization and neuroinflammatory response to citrate-capped
spherical GNP (10 nm) was determined 24 hours after intravenous (IV) injection in male
C57Bl mice. A known inflammogen, lipopolysaccharide (LPS, 2 mg kg-1, SC), was tested
as a positive control supplement. Aggregation of GNPs was measured using various
Phosphate-Buffered Saline (PBS) concentrations (10, 1, 0.1, 0.01 X) to determine the
optimal buffer concentration to maintain GNP solubility. 0.01 X PBS was used in all
studies, since it produced the least amount of GNP aggregation. The next experiment
verified entry of GNPs into the CNS. Mice were injected IV (200 µg mL-1 10 nm GNP in
0.01 X PBS) via the tail vein. After 24 hours mice were euthanized (with 130 mg ml-1
Euthasol), and perfused transcardially (with 2% glutaraldehyde and 2%
paraformaldehyde), then brains were removed. GNP concentrations were measured using
inductively coupled plasma mass spectrometry in whole brain homogenates. To
specifically localize accumulation of GNPs in brain, septum, caudate, hippocampus,
hypothalamus, cortex, frontal cortex, and spinal cord regions were micro dissected.
Hypothalamus, hippocampus, and septum had the highest GNP levels (6.7, 6.2, and 4.6
µg Au g-1 tissue respectively). To evaluate brain inflammation, we used q-PCR analysis
of frozen brain regions for study of pro-inflammatory mediators, Leukemia inhibitory
factor (LIF), CC chemokine ligand 2 (CCL2) and Interleukine-1 ß (IL-1ß). GNPs did not
affect cytokine/chemokine expression in cortex, frontal cortex or hippocampus. LPS
(positive control), as expected, caused a marked (100-fold) increase in the same
cytokines. Results show that GNPs enter brain and concen (open full item for complete abstract)
Committee: Mariana Morris Ph.D. (Advisor); Saber M. Hussain Ph.D. (Advisor); Ioana Pavel Sizemore Ph.D. (Committee Member)
Subjects: Biomedical Research; Environmental Science; Health Sciences; Medicine; Nanoscience; Nanotechnology; Neurobiology; Neurosciences; Pharmacology; Toxicology